Poor injection angles, repeated use of the same injection site, or muscle injection instead of subcutaneous injection can reduce bioavailability
Key Considerations in Use of SGLT2 Inhibitors and GLP-1RAs for CV Risk Reduction in Patients with T2D. American College of Cardiology , Aug
Patients may encounter compounded semaglutide if brand-name products are on backorder or if a prescriber is seeking a very specific dosing option that isnt offered by the manufacturer
Seek medical attention promptly if you experience symptoms that could suggest serious underlying conditions, including: Unexplained weight loss or persistent fatigue Jaundice (yellowing of skin or eyes), abdominal pain, or swelling Easy bruising or bleeding , or unusual skin rashes Night sweats , fever, or enlarged lymph nodes Reduced urine output , significant swelling in legs or ankles Persistent itching without obvious skin cause These symptoms may indicate liver disease, haematological disorders, or renal impairmentconditions that can elevate B12 and require specialist assessment
Direct Effects on the Optic Nerve: Some research suggests that GLP-1 receptors are present in the optic nerve, raising the possibility that these drugs may directly affect neural tissue in ways that increase vulnerability to ischemia